Retirement Systems of Alabama reduced its stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 0.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,566 shares of the biotechnology company’s stock after selling 118 shares during the period. Retirement Systems of Alabama’s holdings in Axon Enterprise were worth $8,187,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently made changes to their positions in the stock. Blue Trust Inc. lifted its stake in shares of Axon Enterprise by 33.1% in the 1st quarter. Blue Trust Inc. now owns 169 shares of the biotechnology company’s stock worth $89,000 after acquiring an additional 42 shares during the period. Advisory Resource Group lifted its stake in Axon Enterprise by 10.9% during the first quarter. Advisory Resource Group now owns 1,884 shares of the biotechnology company’s stock valued at $991,000 after purchasing an additional 185 shares during the last quarter. Wealthspan Partners LLC lifted its stake in Axon Enterprise by 3.4% during the first quarter. Wealthspan Partners LLC now owns 894 shares of the biotechnology company’s stock valued at $470,000 after purchasing an additional 29 shares during the last quarter. Premier Path Wealth Partners LLC lifted its stake in Axon Enterprise by 17.4% during the first quarter. Premier Path Wealth Partners LLC now owns 438 shares of the biotechnology company’s stock valued at $230,000 after purchasing an additional 65 shares during the last quarter. Finally, State of Alaska Department of Revenue lifted its stake in Axon Enterprise by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 8,489 shares of the biotechnology company’s stock valued at $4,464,000 after purchasing an additional 230 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Axon Enterprise news, President Joshua Isner sold 905 shares of the stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total value of $702,632.95. Following the completion of the sale, the president now owns 268,735 shares in the company, valued at $208,643,166.65. This represents a 0.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Jennifer H. Mak sold 75 shares of the stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $771.81, for a total transaction of $57,885.75. Following the completion of the sale, the chief accounting officer now owns 15,240 shares of the company’s stock, valued at approximately $11,762,384.40. The trade was a 0.49% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock worth $30,500,428 in the last quarter. 5.70% of the stock is currently owned by corporate insiders.
Axon Enterprise Stock Up 0.8%
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. During the same quarter in the previous year, the business earned $1.15 earnings per share. The firm’s revenue was up 31.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.
Wall Street Analysts Forecast Growth
Several analysts recently commented on the stock. Bank of America increased their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a “buy” rating in a research note on Wednesday, June 4th. Needham & Company LLC increased their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a research note on Thursday, May 8th. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a “buy” rating in a research note on Wednesday, May 14th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Finally, Barclays increased their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a research note on Friday, May 9th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $699.55.
View Our Latest Analysis on AXON
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories
- Five stocks we like better than Axon Enterprise
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Microsoft Stock Holds Steady as AI Drives Workforce Shift
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- D-Wave Goes International With South Korea Partnership
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.